AG1321001(drug)
Phase 3Small molecule
Ahn-Gook Pharmaceuticals Co.,LtdAG1321001(drug) is one of 32 small molecule programs targeting Chronic Cough. It is currently in Phase 3.
1
Indications
1
Total Trials
0
Active Trials
31
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
48 competitors in Chronic Cough
#DrugCompanyPhaseTrials
1Singulair
OOrganon and Co
Approved
Lyrica
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Aspercreme Warming
AAveritas Pharma, Inc.
Approved
Nucala
GGlaxo Dba Glaxosmithkline
Approved
Nexium
DDexcel Pharma Technologies Ltd.
Approved
Quietus
Merck & Co.Phase 2
Indocin
LLife Extension Foundation Inc.
Phase 3
Prilosec
DDexcel Pharma Technologies Ltd.
Phase 3
Cymbalta
Alnylam PharmaceuticalsPhase 2
Elavil
AstraZenecaPhase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for AG1321001(drug). EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details